Stay updated with breaking news from Cell Type Specific Expression. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Parkinson's disease is a progressive disorder that is caused by the degeneration of nerve cells in the part of the brain called the substantia nigra, which...
WASHINGTON (dpa-AFX) - Neurocrine Biosciences Inc. (NBIX) and Voyager Therapeutics Inc. (VYGR) said that they have collaborated to advance multiple gene therapies for the treatment of neurological
Voyager Therapeutics has promising technology. But the stock is very risky.
Voyager receives $54 million upfront with potential option exercise fees and milestone payments of up to $1.7 billion plus product sales-based royalties ...
08.03.2022 - Voyager receives $54 million upfront with potential option exercise fees and milestone payments of up to $1.7 billion plus product sales-based royalties Novartis receives target-specific access to Voyager’s novel TRACER AAV capsids for potential ... Seite 1